Eurofarma Innovation and Growth Strategy
6
eurofarma
COMPLETE PORTFOLIO
Growth Profile
Institutional
1H22 Consolidated Net Sales1
R$3.9 bi (+12.5% vs. 1H21)
Prescription
63,4%
Generic
16,4%
Hospitals
7,7%
Oncologic 2,3%
Public Sector
5,1%
Others2 23
5,1%
Prescription
#1 9.6% market share
(Close-up)
#2 6.2% market share
Generic
(IQVIA)
market share
#2 14.2% (IQVIA)
Hospitals
#7 3.8% market share #1
Oncologic
(IQVIA)
#11 1.6% market share #32
(IQVIA)
Public Sector (Bids)
market share
#19 1.5% (QVIA)
Latin America
#3 3.4% market share
(IQVIA)
Regional-based pharma4
(IQVIA)
#2
Brazil 5
#3 5.9% market share
(IQVIA)
1- Eurofarma Corp (Eurofarma+Momenta+Supera) / 2- OTC + Outsourcing Services + Exports / 3- Excluding multinational pharma companies not based in Brazil / 4- Excluding multinational pharma companies not based in Latin America / 5- Retail Reais PPP / NRA Reais PP (Total
Pharmaceutical Market, excluding Covid-19 vaccines).View entire presentation